Printer Friendly
The Free Library
19,604,538 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Celera Genomics Appoints Jason Molle as Senior Vice President of Sales and Marketing.


Business Editors/Health & Medical Writers

ROCKVILLE, Md.--(BW HealthWire)--June 30, 2000

Celera Genomics (NYSE NYSE

See: New York Stock Exchange
:CRA See Community Reinvestment Act. ), a PE Corporation business, announced today that Jason Molle, has joined Celera as senior vice president of sales and marketing.

In this new position, Molle will lead the database subscription business line sales marketing functions. Specifically, he will be responsible for identifying target markets and effective strategies for product development and for leading the market activities that integrate the sales, product, and customer support teams.

Molle comes to Celera from the Dialog Corporation Plc. and brings with him more than 10 years of sales, marketing and product development experience in the online Internet market. Most recently he served as president of North American operations North American operation Surgical oncology Radical surgery of a 'frozen pelvis', consisting of radical en bloc resection of the uterus and urinary bladder. See 'Frozen pelvis.'. Cf 'All-American' and 'South American' operations. . In this position he was responsible for North and South America South America, fourth largest continent (1991 est. pop. 299,150,000), c.6,880,000 sq mi (17,819,000 sq km), the southern of the two continents of the Western Hemisphere.  and Canada and led a multi-million dollar information services See Information Systems. , CD-ROM CD-ROM: see compact disc.
CD-ROM
 in full compact disc read-only memory

Type of computer storage medium that is read optically (e.g., by a laser).
, web and E-commerce business. In earlier roles he was responsible for developing the North American operations of M.A.I.D., Plc and developed Profound.com into a market leading service for business intelligence on the web.

"Jason's global marketing and sales experience in e-commerce make him ideal to lead Celera's expanding database business," said J. Craig Venter The introduction of this article is too short.
To comply with Wikipedia's lead section guidelines, it should be expanded.
, PhD, Celera's president and chief scientific officer. "We look forward to using his expertise in leveraging information technology to enhance Celera's business as we move beyond building reference databases toward comparative genomics, proteomics, and personalized medicine."

Currently, Celera's information is available through the Internet on a subscription basis to academic and commercial institutions. Users have the ability to view, browse, and analyze data in an integrated way.

PE Corporation comprises two operating groups. The Celera Genomics Group, headquartered in Rockville, MD, intends to become the definitive source of genomic and related medical information. The PE Biosystems Group (NYSE:PEB PEB Physical Evaluation Board
PEB Presidential Emergency Board
PEB Post Exposure Bake
PEB Professional Engineers Board (Singapore)
PEB Pre-Engineered Building
PEB Personal Electronic Ballot
PEB Performance Evaluation Board
), with sales of $1.2 billion during fiscal 1999, develops and markets instrument-based systems, reagents, software and contract services to the life science industry and research community. PE Biosystems is headquartered in Foster City, CA, and comprises four divisions: Applied Biosystems, PE Informatics, PerSeptive Biosystems, and Tropix. Information about the company, including reports and other information filed by the company with the Securities and Exchange Commission, is available on the worldwide web at www.pecorporation.com or by phoning 800/762-6923.

Note to Editors: Celera, Celera Genomics, and PE Biosystems are trademarks of PE Corporation.
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 30, 2000
Words:393
Previous Article:Public Storage Announces Dividend on Adjustable Rate Cumulative Preferred Stock.
Next Article:Developer Says School District Tries to Duck Responsibility With Ill-Conceived Belmont Lawsuit.
Topics:



Related Articles
Celera Genomics Appoints Chief Operating Officer; Peter Chambre, CEO of Bespak plc to Lead Operations.
Celera Genomics Reports Revenue Growth From Subscriptions in Fourth Quarter; Revenues Rise to $15.0 Million, Up From $5.1 Million in Prior Year.
Celera and ValiGen Sign Genomics Agreement.
Celera Genomics Signs Genset to Database Subscription Deal.
Applera Corporation Announces Three Investor Relations Appointments.
GeneFormatics' Structural Proteomics Database Available Through the Celera Discovery System.
Inpharmatica and Celera Genomics to Jointly Develop New Version of Biopendium, Drug Target Discovery Platform.
John Wiley and Sons, Inc., and Celera Genomics Announce Linking Agreement; Wiley InterScience to Link with Celera Discovery System.
CELERA EXPANDS GENOMIC PROGRAM.
Applera Announces New Applied Biosystems Knowledge Business and Marketing and Distribution Agreement for Celera Discovery System 'CDS'.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles